Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (151-160 of 283) with videos related to

Pageof 29
Sort By:
Molecular Carcinogenesis|June 18, 2016
The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapyYasutaka Matsunaga, Yasushi Adachi, Yasushi Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung CancerErica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Molecular Cancer Therapeutics|June 21, 2008
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomasWenhua Piao, Yu Wang, Yasushi Adachi, et al.
Carcinogenesis|December 22, 2006
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinomaArisa Imsumran, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Cancer Medicine|December 15, 2025
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United StatesAlexander J Didier, Charlotte Lennox, Mingjia Li, et al.
Cancer Research|August 17, 2006
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancerHeath B Acuff, Mark Sinnamon, Barbara Fingleton, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2021
The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and OpportunitiesRaymond U Osarogiagbon, Ramon Rami-Porta, Ming Sound Tsao, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2011
Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometryHaixia Zhang, Qinfeng Liu, Lisa J Zimmerman, et al.
Pageof 29

Showing results (151-160 of 283) with videos related to

Sort By:
Pageof 29
Molecular Carcinogenesis|June 18, 2016
The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapyYasutaka Matsunaga, Yasushi Adachi, Yasushi Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung CancerErica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Molecular Cancer Therapeutics|June 21, 2008
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomasWenhua Piao, Yu Wang, Yasushi Adachi, et al.
Carcinogenesis|December 22, 2006
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinomaArisa Imsumran, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Cancer Medicine|December 15, 2025
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United StatesAlexander J Didier, Charlotte Lennox, Mingjia Li, et al.
Cancer Research|August 17, 2006
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancerHeath B Acuff, Mark Sinnamon, Barbara Fingleton, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2021
The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and OpportunitiesRaymond U Osarogiagbon, Ramon Rami-Porta, Ming Sound Tsao, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2011
Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometryHaixia Zhang, Qinfeng Liu, Lisa J Zimmerman, et al.
Pageof 29